[ProjectArcturis]

Yeah. This is regulatory arbitrage. It costs a lot to get certified to produce a medication (which is necessary, or else some company will cut corners and produce a contaminated drug). For drugs with small patient populations, it doesn't make sense to pay for that certification and then sell it cheaply. So the drug ends up being made by only a few manufacturers and the price stays high even though it's a generic. I don't know what a better solution is.

[TrueGeek]

I’d buy that argument if their balance sheet didn’t show the vast majority of their budget going to advertising and if companies like CostPlusDrugs weren’t able to do it for pennies.

[ProjectArcturis]

What company are you talking about? What drug? If CostPlusDrugs can do it for pennies, why not buy from them?